(Reuters) - Medtronic Inc said on Tuesday it agreed to pay royalties to rival medical device maker Edwards Lifesciences Corp in a settlement that allows Medtronic to continue to sell its CoreValve replacement heart valves. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/u62x7UMNBog/story01.htm
Read More
No comments:
Post a Comment